VANCOUVER, BC and
MESA, AZ, June 19, 2013 /PRNewswire/ - Avidus Management
Group Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) and
its wholly owned subsidiary, Asantae, today announced that it held
strategic meetings for its key distributors at an exclusive resort
in Scottsdale, Arizona during the
weekend of June 9th.
At the meeting, a standardized plan for
leadership, events, recognition, awards, and training systems was
introduced. Avidus' new President, Doug
Ridley said, "The key to growth and sustainability in
network-marketing revolves around a standardized system and model
for sales, recruiting, and distributor development. I was
excited to introduce these programs to those in attendance."
Mr. Ridley also revealed F.A.S.T., an Avidus
developed training system for network marketers. He
commented, "F.A.S.T. is the backbone upon which we will create and
introduce our distributor tools. It is a disciplined and
duplicable system for building and sustaining long-term growth in
network-marketing."
In addition, insight was given to the near-term
product roadmap. Dan Lundell,
Avidus CEO, explained, "Our product development program strictly
adheres to our core mission to address chronic low-grade
inflammation, which is among the leading causes of modern disease.
I look forward to revealing more information about our newest
product next month."
Additional information about the new product
launch will be announced in July.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
About Avidus
Avidus Management Group Inc. (www.asantae.com)
(TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary,
Asantae, is a producer and marketer of innovative nutritional
products through direct and network marketing channels. The
ingredients in Avidus' products have been shown to reduce chronic
low-grade inflammation and oxidative stresses which, according to
scientific and medical research, are the underlying conditions for
most modern epidemic diseases (diabetes, heart disease, obesity,
stroke, etc.).
This news release may contain forward-looking statements
relating to the Company's operations or to the environment in which
it operates. Such statements are based on operations, estimates,
forecasts and projections. They are not guarantees of future
performance and involve risks and uncertainties that are difficult
to predict and may be beyond the Company's control. A number of
important factors could cause actual outcomes and results to differ
materially from those expressed in forward-looking statements,
including those set forth in the Company's regulatory filings. In
addition, such statements relate to the date on which they are made
and the Company disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, save and except as may be
required by applicable securities laws.
SOURCE Avidus Management Group Inc.